Parallel Advisors’s Hims & Hers Health HIMS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$75.8K Buy
2,184
+1,464
+203% +$39.3K ﹤0.01% 1881
2026
Q1
$14.9K Sell
720
-614
-46% -$14.5K ﹤0.01% 2594
2025
Q4
$43.3K Buy
1,334
+50
+4% +$2.14K ﹤0.01% 1916
2025
Q3
$72.8K Buy
1,284
+129
+11% +$6.61K ﹤0.01% 1587
2025
Q2
$57.6K Buy
1,155
+735
+175% +$33.2K ﹤0.01% 1640
2025
Q1
$12.4K Buy
420
+329
+362% +$12.2K ﹤0.01% 2349
2024
Q4
$2.2K Buy
91
+24
+36% +$595 ﹤0.01% 2938
2024
Q3
$1.23K Sell
67
-10
-13% -$179 ﹤0.01% 2992
2024
Q2
$1.55K Buy
+77
New +$1.28K ﹤0.01% 2862
2021
Q1
Sell
-50
Closed -$1K 2837
2020
Q4
$1K Buy
+50
New +$555 ﹤0.01% 2430

Other funds holding HIMS

Parallel Advisors's HIMS Position: Q2 2026 in Review

Parallel Advisors increased its Hims & Hers Health (HIMS) stake by 203% in Q2 2026, buying an estimated $39.3K and bringing the position to 2,184 shares worth $75.8K. The position accounts for ﹤0.01% of the portfolio, ranked #1881.

Parallel Advisors first reported a position in HIMS in Q4 2020 and has held it in 10 quarters since. 506 funds tracked by Wall St. Rank hold HIMS as of Q2 2026.

  • Parallel Advisors held 2,184 shares of Hims & Hers Health worth $75.8K as of Q2 2026.
  • Parallel Advisors bought 1,464 Hims & Hers Health shares in Q2 2026, an estimated $39.3K.
  • Hims & Hers Health made up ﹤0.01% of Parallel Advisors's portfolio in Q2 2026, its #1881 holding.
  • Parallel Advisors first reported a position in Hims & Hers Health in Q4 2020 and has held it in 10 quarters since.
  • 506 funds tracked by Wall St. Rank held Hims & Hers Health as of Q2 2026.

Based on Parallel Advisors's 13F filing for Q2 2026, filed 5 Aug 2026.